- Latest available (Revised)
- Point in Time (20/07/2009)
- Original (As adopted by EU)
Directive 2001/82/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to veterinary medicinal products
When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.
Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).
EU Directives are published on this site to aid cross referencing from UK legislation. Since IP completion day (31 December 2020 11.00 p.m.) no amendments have been applied to this version.
The summary of the product characteristics shall contain, in the order indicated below, the following information:
name of the veterinary medicinal product followed by the strength and the pharmaceutical form;
qualitative and quantitative composition in terms of the active substances and constituents of the excipient, knowledge of which is essential for proper administration of the medicinal product. The usual common name or chemical description shall be used;
pharmaceutical form;
clinical particulars:
target species,
indications for use, specifying the target species,
contra-indications,
special warnings for each target species,
special precautions for use, including special precautions to be taken by the person administering the medicinal product to the animals,
adverse reactions (frequency and seriousness),
use during pregnancy, lactation or lay,
interaction with other medicinal products and other forms of interaction,
amounts to be administered and administration route,
overdose (symptoms, emergency procedures, antidotes), if necessary,
withdrawal periods for the various foodstuffs, including those for which the withdrawal period is zero;
pharmacological properties:
pharmacodynamic properties,
pharmacokinetic particulars;
pharmaceutical particulars:
list of excipients,
major incompatibilities,
shelf life, when necessary after reconstitution of the medicinal product or when the immediate packaging is opened for the first time,
special precautions for storage,
nature and composition of immediate packaging,
special precautions for the disposal of unused veterinary medicinal products or waste materials derived from the use of such products, if appropriate;
marketing authorisation holder;
marketing authorisation number(s);
date of the first authorisation or date of renewal of the authorisation;
date of revision of the text.
For authorisation under Article 13, those parts of the summary of product characteristics of the reference medicinal product referring to indications or dosage forms which were still covered by patent law at the time when a generic medicine was marketed need not be included.]
The Whole Directive you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
The Schedules you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.
Point in Time: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.
The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.
For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: